Post by Headache Journal (Headache: The Journal of Head & Face Pain)

Chronic #migraine remains a major challenge in #neurology, especially when complicated by medication overuse. This new systematic review and meta-analysis evaluates the evidence for the #CGRP mAb, #erenumab, in this patient population. 🔍 The study synthesizes data from multiple trials to assess: * Reduction in monthly migraine days * Impact of medication overuse on treatment response * Overall tolerability and safety 💡 Findings support the efficacy and safety of erenumab for patients with chronic migraine, including those with medication overuse, offering valuable insights for clinical decision-making. Read the full article using this direct link 👉 https://lnkd.in/gdbjvv9q REBECA OLIVEIRA DA SILVA, Frederico de Sousa Marinho Mendes Filho, João Guilherme Gomes Pedrosa, Giovanna Salema Pascual, Saul Dominici, Elizabet Taylor Pimenta Weba, Christian Ken Fukunaga, David Abraham Batista da Hora, Ocílio Ribeiro Gonçalves, Rafaela Farias Vidigal Nascimento MD, Daniel Vicente de Siqueira Lima MD